Figure 1.

Change in 24-h mean systolic ambulatory blood pressure (mmHg) and mean diastolic ambulatory blood pressure (mmHg) from baseline with lumiracoxib and ibuprofen for 4 weeks in patients with well-controlled hypertension on (A) angiotensin receptor blocker monotherapy and (B) angiotensin-converting enzyme inhibitor monotherapy (ITT population). ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; Est. Diff., estimated treatment difference; ITT, intention-to-treat; MDABP, mean diastolic ambulatory blood pressure; MSABP, mean systolic ambulatory blood pressure; od, once daily; tid, three times daily. Treatment analysed using an analysis of covariance (ANCOVA) with treatment as main effect and centre and baseline 24-h MSABP as covariates